46 programming-"the"-"DAAD"-"U"-"IMPRS-ML"-"FEMTO-ST"-"PDI-Service" "UCL" "UCL" Fellowship positions
Sort by
Refine Your Search
-
About us University College London (UCL) UCL is a multi-disciplinary university with a population of over 13,000 staff and 42,000 students from 150 different countries. Degree programmes
-
– fitness made convenient Employee Assistance Programme – for confidential wellbeing support when you need it Whether you're looking to grow your career or simply find a better balance, UCL could be the right
-
About us The UCL Institute for Global Health (IGH) is at the heart of UCL’s Grand Challenge of Global Health. The Institute’s vision is for a world where international policy on global health is
-
work on the genomics of epilepsy within a wider programme of translational research, including genomics and climate change, under the supervision of Professor Sanjay Sisodiya. You will oversee a team of
-
About us The UCL Institute for Global Health (IGH) is at the heart of UCL’s Grand Challenge of Global Health. The Institute’s vision is for a world where international policy on global health is
-
. UCL is ranked 9th in the 2024 QS World University Rankings, 2nd in the UK for research power (Research Excellence Framework 2021) and our Neuroscience degree is ranked first in Europe (U.S. News and
-
organoid models of neurodevelopmental diseases to test advanced genetic therapies. It will be supervised by Professor Gabriele Lignani and is in collaboration with Dr Amy McTague at UCL Institute of Child
-
. UCL is ranked 9th in the 2024 QS World University Rankings, 2nd in the UK for research power (Research Excellence Framework 2021) and our Neuroscience degree is ranked first in Europe (U.S. News and
-
About us The “Next-Gen Biopharma Manufacturing 5.0” Prosperity Partnership is a 5-year collaborative programme between UCL Biochemical Engineering and AstraZeneca, jointly funded by EPSRC and
-
About us The “Next-Gen Biopharma Manufacturing 5.0” Prosperity Partnership is a 5-year collaborative programme between UCL Biochemical Engineering and AstraZeneca, jointly funded by EPSRC and